Lv1
18 积分 2025-05-25 加入
Protein engineering approach to enhance activity assays of mono-ADP-ribosyltransferases through proximity
4个月前
已完结
1,5,7‐Triazabicyclo[4.4.0]dec‐5‐ene (TBD): An Organocatalyst for Rapid Access to 3‐Hydroxyisoindolin‐1‐ones
4个月前
已完结
Discovery of Fused Isoquinolinone/Triazole as a Scaffold for Tankyrase and PARP Inhibition
4个月前
已完结
Discovery of Fused Isoquinolinone/Triazole as a Scaffold for Tankyrase and PARP Inhibition
4个月前
已完结
RP12146, a novel, selective, and potent small molecule inhibitor of PARP 1/2, synergizes with SOC therapy in preclinical models of solid tumors
4个月前
已完结
Olaparib: First Global Approval
4个月前
已完结
PARP7: an Emerging Therapeutic Target-Insights into Biological Functions and Advances in Small-Molecule Inhibitor Development
4个月前
已完结
A Simple Method to Study ADP-Ribosylation Reversal: From Function to Drug Discovery
5个月前
已完结
Rational design of selective inhibitors of PARP4
6个月前
已完结
Discovery and Optimization of Potent and Highly Selective PARP14 Inhibitors for the Treatment of Atopic Dermatitis
6个月前
已完结
皖公网安备34019202002308
